Skip to main content Accessibility help
×
Home

Nodding syndrome research, lessons learned from the NSETHIO project

  • D. Geelhand de Merxem (a1), J. N. Siewe Fodjo (a1), S. Menon (a1), A. Hotterbeekx (a1) and R. Colebunders (a1)...

Abstract

Background.

Until recently, nodding syndrome (NS) was considered as a mysterious disease of unknown etiology. A link between onchocerciasis and epilepsy was suspected for a long time. However, onchocerciasis was not considered as the cause of NS because NS was believed to occur only in onchocerciasis-endemic regions in Uganda, South Sudan, and Tanzania. In October 2015, with funding from the European Research Council, the NSETHIO group launched a trans-disciplinary, multi-country research project to identify the cause of NS and to study the link between onchocerciasis and epilepsy.

Methods.

We reviewed NSETHIO activities as well as all published papers, and compared project findings with results of previous research on NS.

Results

Findings from the NSETHIO project showed that NS is only one of the clinical manifestations in the wide spectrum of onchocerciasis-associated epilepsy (OAE) that could be prevented by strengthening onchocerciasis elimination programs. NSETHIO demonstrated that OAE is an important neglected public health problem in onchocerciasis-endemic areas with no or a sub-optimally functioning onchocerciasis control strategies.

Conclusions.

Today there is overwhelming evidence that NS together with the Nakalanga syndrome is clinical presentations of OAE, a condition that could be prevented by strengthening onchocerciasis elimination programs. While research needs to continue to elucidate the pathophysiological mechanisms causing NS, new strategies to accelerate onchocerciasis elimination coupled with community-based surveillance and treatment programs for epilepsy are urgently needed in areas of high Onchocerca volvulus transmission.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Nodding syndrome research, lessons learned from the NSETHIO project
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Nodding syndrome research, lessons learned from the NSETHIO project
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Nodding syndrome research, lessons learned from the NSETHIO project
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

*Address for correspondence: D. Geelhand de Merxem, Global Health Institute, University of Antwerp Campus Drie Eiken, Room D.S.036 Universiteitsplein 1–2610 Wilrijk, Belgium. (Email: dimitri.geelhanddemerxem@uantwerpen.be)

References

Hide All
Boullé, C, Njamnshi, AK, Dema, F, Mengnjo, MK, Siewe Fodjo, JN, Bissek, ACZ-K, Suykerbuyk, P, Lenou-Nanga, CG, Nana-Djeunga, HC, Kamgno, J, Chesnais, CB, Boussinesq, M, Colebunders, R (2019). Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon. Parasites & Vectors 12, 114.
Boussinesq, M, Pion, SD, Ngangue, D, Kamgno, J (2002). Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 537541.
Cantey, PT, Rout, J, Rao, G, Williamson, J, Fox, LM (2010). Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Neglected Tropical Diseases 4, e728.
Casis, S (1938). El Sindrome Epileptico y sus reaciones con Onchocercosis. Boletin de Salubridad e Higiene (Mexico) 1, 1131.
Chesnais, CB, Nana-Djeunga, HC, Njamnshi, AK, Lenou-Nanga, CG, Boulle, C, Bissek, AZ, Kamgno, J, Colebunders, R, Boussinesq, M (2018). The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study. The Lancet Infectious Diseases 18, 12781286.
Colebunders, R, Abd-Elfarag, G, Carter, JY, Olore, PC, Puok, K, Menon, S, Siewe Fodjo, JN, Bhattacharyya, S, Ojok, M, Lako, R, Logora, MY (2018 a). Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan. Seizure 62, 108115.
Colebunders, R, Carter, JY, Olore, PC, Puok, K, Bhattacharyya, S, Menon, S, Abd-Elfarag, G, Ojok, M, Ensoy-Musoro, C, Lako, R, Logora, MY (2018 b). High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: a community-based survey. Seizure 3, 93101.
Colebunders, R, Hendy, A, Mokili, JL, Wamala, JF, Kaducu, J, Kur, L, Tepage, F, Mandro, M, Mucinya, G, Mambandu, G, Komba, MY, Lumaliza, JL, Van Oijen, M, Laudisoit, A (2016 a). Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda. BMC Research Notes 9, 182.
Colebunders, R, Hendy, A, Nanyunja, M, Wamala, JF, Van Oijen, M (2014). Nodding syndrome-a new hypothesis and new direction for research. International Journal of Infectious Diseases 27, 7477.
Colebunders, R, Mandro, M, Mokili, JL, Mucinya, G, Mambandu, G, Pfarr, K, Reiter-Owona, I, Hoerauf, A, Tepag, F, Levick, B, Begon, M, Laudisoit, A (2016 b). Risk factors for epilepsy in Bas-Uele Province, Democratic Republic of the Congo: a case-control study. International Journal of Infectious Diseases 49, 18.
Colebunders, R, Mandro, M, Njamnshi, AK, Boussinesq, M, Hotterbeekx, A, Kamgno, J, O'Neill, S, Hopkins, A, Suykerbuyk, P, Basáñez, MG, Post, RJ, Pedrique, B, Preux, PM, Stolk, WA, Nutman, TB, Idro, R (2018 c). Report of the first international workshop on onchocerciasis-associated epilepsy. Infectious Diseases of Poverty 7(1).
Colebunders, R, Njamnshi, AK, Van Oijen, M, Mukendi, D, Kashama, JM, Mandro, M, Gumisiriza, N, Preux, PM, Suykerbuyk, P, Idro, R (2017). Onchocerciasis-associated epilepsy: from recent epidemiological and clinical findings to policy implications. Epilepsia Open 2, 145152.
Colebunders, R, Siewe, FJN, Hotterbeekx, A (2018 d). Onchocerciasis-associated epilepsy, an additional reason for strengthening onchocerciasis elimination programs. Trends in Parasitology 34, 208216.
Colebunders, R, Siewe Fodjo, JN, Hopkins, A, Hotterbeekx, A, Lakwo, TL, Kalinga, A, Logora, MY, Basanez, MG (2019). From river blindness to river epilepsy: implications for onchocerciasis elimination programmes. PLoS Neglected Tropical Diseases 13, e0007407.
Colebunders, R, Titulaer, MJ (2017). Nodding syndrome: preventable and treatable. Science Translational Medicine 9(377), eaam8532.
Dadzie, Y, Amazigo, UV, Boatin, BA, Seketeli, A (2018). Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes. Infectious Diseases of Poverty 7, 63.
Diagana, M, Preux, PM, Tuillas, M, Ould Hamady, A, Druet-Cabanac, M (2006). Depistage de l'epilepsie en zones tropicales: validation d'un questionnaire en Mauritanie. Bulletin de la Societe de Pathologie Exotique 99, 103107.
Dolo, H, Mandro, M, Wonya'rossi, D, Ngave, F, Fraeyman, J, Siewe, JN, Suykerbuyk, P, Colebunders, R (2018). Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo. Infectious Diseases of Poverty 7, 115.
Duke, BO, Vincelette, J, Moore, PJ (1976). Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine. Tropenmedizin und Parasitologie 27, 123132.
Foltz, JL, Makumbi, I, Sejvar, JJ, Malimbo, M, Ndyomugyenyi, R, Atai-Omoruto, AD, Alexander, LN, Abang, B, Melstrom, P, Kakooza, AM, Olara, D, Downing, RG, Nutman, TB, Dowell, SF, Lwamafa, DK (2013). An epidemiologic investigation of potential risk factors for nodding syndrome in Kitgum District, Uganda. PLoS ONE 8, e66419.
Gerrits, C (1983). A West African epilepsy focus. Lancet 1, 358.
Hissette, J (1932). Memoire sur l'Onchocerca volvulus “Luecart” et ses manifestations oculaires au Congo Belge.
Hotterbeekx, A, Lammens, M, Idro, R, Akun, PR, Lukande, R, Akena, G, Nath, A, Taylor, J, Olwa, F, Kumar-Singh, S, Colebunders, R (2019). Neuroinflammation and not tauopathy is a predominant pathological signature of nodding syndrome. Journal of Neuropathology and Experimental Neurology doi: 10.1093/jnen/nlz090.
Jilek-Aall, L (1964). Mental diseases and epilepsy in Tropical Africa. Fortschr Neurol Psychiatr Grenzgeb, 32, 213259.
Jilek-Aall, L (2004). Epilepsy and onchocerciasis: pioneering research of Mexican physicians vindicated. Investigacion en Salud 6, 2227.
Kaiser, C, Mmbando, BP, Siewe Fodjo, JN, Suykerbuyk, P, Mnacho, M, Kakorozya, A, Matuja, W, Hendy, A, Greter, H, Makunde, WH, Colebunders, R (2019). Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania. Infectious Diseases of Poverty 8, 35.
Kipp, W, Kasoro, S, Burnham, G (1994). Onchocerciasis and epilepsy in Uganda. Lancet 343, 183184.
Kirk, R, Morgan, HV, Haseeb, MA, Satti, MH (1959). Onchocerciasis in the Sudan Republic. Annals of Tropical Medicine & Parasitology 53, 97102.
König, R, Nassri, A, Meindl, M, Matuja, W, Kidunda, AR, Siegmund, V, Bretzel, G, Loscher, T, Jilek-Aall, L, Schmutzhard, E, Winkler, AS (2010). The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania. Parasitology 137, 15591568.
Lacey, M (2003). Nodding disease: mystery of southern Sudan. Lancet Neurology 2, 714.
Lenaerts, E, Mandro, M, Mukendi, D, Suykerbuyk, P, Dolo, H, Wonya'rossi, D, Ngave, F, Ensoy-Musoro, C, Laudisoit, A, Hotterbeekx, A, Colebunders, R (2018). High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo. Infectious Diseases of Poverty 7, 68.
Levick, B, Laudisoit, A, Tepage, F, Ensoy-Musoro, C, Mandro, M, Bonareri Osoro, C, Suykerbuyk, P, Kashama, JM, Komba, M, Tagoto, A, Falay, D, Begon, M, Colebunders, R (2017). High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo. PLoS Neglected Tropical Diseases 11, e0005732.
Mandro, M, Suykerbuyk, P, Tepage, F, Rossy, D, Ngave, F, Hasan, MN, Hotterbeekx, A, Mambandu, G, Kashama, JM, Laudisoit, A, Colebunders, R (2018). Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study. Infectious Diseases of Poverty 7, 79.
Mbonye, MK, Gumisiriza, N, Lakwo, T, Makumbi, I, Idro, R, Onen, H, Colebunders, R. (2017) Prevalence and annual incidence of nodding syndrome and other forms of epilepsy in onchocerciasis endemic areas in northern Uganda. 1st international workshop on onchocerciasis-associated epilepsy. Antwerp, Belgium. Abstract 24 (http://www.uantwerpen.be/oaebooklet).
Mmbando, BP, Suykerbuyk, P, Mnacho, M, Kakorozya, A, Matuja, W, Hendy, A, Greter, H, Makunde, WH, Colebunders, R (2018). High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin. Infectious Diseases of Poverty 7, 64.
Mukendi, D, Tepage, F, Akonda, I, Siewe, JNF, Rotsaert, A, Ndibmun, CN, Laudisoit, A, Couvreur, S, Kabutako, B, Menon, S, Hotterbeekx, A, Colebunders, R (2019). High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: a mixed-method assessment. International Journal of Infectious Diseases 79, 187194.
Pollanen, MS, Onzivua, S, Robertson, J, Mckeever, PM, Olawa, F, Kitara, DL, Fong, A (2018). Nodding syndrome in Uganda is a tauopathy. Acta Neuropathologica 136, 691697.
Raper, AB, Ladkin, RG (1950). Endemic dwarfism in Uganda. East African Medical Journal 27, 339359.
Raz, L, Bhaskar, K, Weaver, J, Marini, S, Zhang, Q, Thompson, JF, Espinoza, C, Iqbal, S, Maphis, NM, Weston, L, Sillerud, LO, Caprihan, A, Pesko, JC, Erhardt, EB, Rosenberg, GA (2018). Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction. Neurobiology of Disease 126, 124136.
Santangelo, R, Cecchetti, G, Bernasconi, MP, Cardamone, R, Barbieri, A, Pinto, P, Passerini, G, Scomazzoni, F, Comi, G, Magnani, G (2017). Cerebrospinal fluid amyloid-beta 42, total tau and phosphorylated tau are low in patients with normal pressure hydrocephalus: analogies and differences with Alzheimer's disease. Journal of Alzheimer's Disease 60, 183200.
Siewe, FJN, Colebunders, R (2019). Intervention for reducing epilepsy-associated stigma. Epilepsy & Behavior: E&B 90, 295.
Siewe Fodjo, JN, Dekker, MCJ, Idro, R, Mandro, MN, Preux, PM, Njamnshi, AK, Colebunders, R (2019 a). Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys. Infectious Diseases of Poverty 8(1).
Siewe Fodjo, JN, Mandro, M, Mukendi, D, Tepage, F, Menon, S, Nakato, S, Nyisi, F, Abhafule, G, Wonya'rossi, D, Anyolito, A, Lokonda, R, Hotterbeekx, A, Colebunders, R (2019 b). Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: clinical description and relationship with microfilarial density. PLoS Neglected Tropical Diseases 13, e0007300.
Siewe Fodjo, JN, Ngarka, L, Tatah, G, Mengnjo, MK, Nfor, LN, Chokote, ES, Boullé, C, Nkouonlack, C, Dema, F, Nkoro, GA, Njamnshi, WY, Tabah, EN, Zoung-Kanyi Bissek, AC, Colebunders, R, Njamnshi, AK (2019 c). Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon. Epilepsy & Behavior 90, 7078.
Siewe Fodjo, JN, Tatah, G, Tabah, EN, Ngarka, L, Nfor, LN, Chokote, SE, Mengnjo, MK, Dema, F, Sitouok, AT, Nkoro, G, Ntone, FE, Bissek, ACZK, Chesnais, CB, Boussinesq, M, Colebunders, R, Njamnshi, AK (2018). Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin. Infectious Diseases of Poverty 7(1).
Siewe Fodjo, JN, Ukaga, CN, Nwazor, EO, Nwoke, MO, Nwokeji, MC, Onuoha, BC, Nwanjor, SO, Okeke, J, Osahor, K, Chimechefulam, L, Ogomaka, AI, Amaechi, AA, Ezenwa, CI, Ezike, MN, Ikpeama, C, Nwachukwu, O, Eriama-Joseph, AI, Nwoke, BEB, Colebunders, R (2019 d). Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria. Infectious Diseases of Poverty 8(1).
Tai, XY, Koepp, M, Duncan, JS, Fox, N, Thompson, P, Baxendale, S, Liu, JY, Reeves, C, Michalak, Z, Thom, M (2016). Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections. Brain 139, 24412455.
Tumwine, JK, Vandemaele, K, Chungong, S, Richer, M, Anker, M, Ayana, Y, Opoka, ML, Klaucke, DN, Quarello, A, Spencer, PS (2012). Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan. African Health Sciences 12, 242248.
Van der Waals, FW, Goudsmit, J, Gajdusek, DC (1983). See-ee: clinical characteristics of highly prevalent seizure disorders in the Gbawein and Wroughbarh Clan Region of Grand Bassa County, Liberia. Neuroepidemiology 2(1–2), 3544.
Vinkeles Melchers, NVS, Mollenkopf, S, Colebunders, R, Edlinger, M, Coffeng, LE, Irani, J, Zola, T, Siewe, JN, De Vlas, SJ, Winkler, AS, Stolk, WA (2018). Burden of onchocerciasis-associated epilepsy: first estimates and research priorities. Infectious Diseases of Poverty 7, 101.
World Health Organization (2011). Managing morbidity and preventing disability in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement. Weekly Epidemiological Record 16, 581585.
World Health Organization (2012). International Scientific Meeting on Nodding Syndrome, Kampala, Uganda. (http://www.who.int/neglected_diseases/diseases/Nodding_syndrom_Kampala_Report_2012.pdf)

Keywords

Nodding syndrome research, lessons learned from the NSETHIO project

  • D. Geelhand de Merxem (a1), J. N. Siewe Fodjo (a1), S. Menon (a1), A. Hotterbeekx (a1) and R. Colebunders (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.